- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Omentectomy.
Displaying page 1 of 1.
EudraCT Number: 2012-004103-12 | Sponsor Protocol Number: ISOTOVE | Start Date*: Information not available in EudraCT |
Sponsor Name:Centre Jean Perrin | ||
Full Title: ISOTOVE study Isotopic study of the intraperitoneal distribution of locoregional post surgery chemotherapy for peritoneal carcinomatosis of ovarian origin | ||
Medical condition: peritoneal carcinomatosis of ovarian origin | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004557-17 | Sponsor Protocol Number: CO-338-087 | Start Date*: 2018-09-11 | |||||||||||||||||||||
Sponsor Name:Clovis Oncology, Inc. | |||||||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Pla... | |||||||||||||||||||||||
Medical condition: advanced (FIGO stage III-IV), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer (who responded to front-line platinum-based chemotherapy) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) ES (Ongoing) BE (Ongoing) FI (Completed) PL (Ongoing) GR (Ongoing) DK (Ongoing) CZ (Ongoing) IT (Ongoing) RO (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005050-35 | Sponsor Protocol Number: 30102012 | Start Date*: 2014-12-01 | ||||||||||||||||
Sponsor Name:University Medical Center Groningen | ||||||||||||||||||
Full Title: Phase Ib/II study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced ovarian cancer | ||||||||||||||||||
Medical condition: advanced ovarian cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001437-14 | Sponsor Protocol Number: IRFMN-CRC-7813 | Start Date*: 2019-09-11 | |||||||||||
Sponsor Name:Associazione Chirurghi Ospedalieri Italiani | |||||||||||||
Full Title: Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis. Short and long-term outcom... | |||||||||||||
Medical condition: patients with colorectal carcinoma at high risk peritoneal carcinomatosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023081-52 | Sponsor Protocol Number: ENGOT-EN2-DGCG | Start Date*: 2011-01-25 | ||||||||||||||||
Sponsor Name:Danish Gynaecological Cancer Group (DGCG) | ||||||||||||||||||
Full Title: A phase II Trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer. | ||||||||||||||||||
Medical condition: Endometrial cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: DK (Ongoing) SE (Ongoing) BE (Ongoing) FI (Ongoing) AT (Ongoing) GB (GB - no longer in EU/EEA) ES (Ongoing) DE (Ongoing) IT (Ongoing) NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001836-44 | Sponsor Protocol Number: UCL/11/0119 | Start Date*: 2012-06-11 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: A Phase II Trial to Assess the Activity of TroVax® (MVA-5T4) Versus Placebo in Patients with Relapsed Asymptomatic Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. | |||||||||||||
Medical condition: Patients with relapsed asymptomatic epithelial ovarian, fallopian tube or primary peritoneal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012859-21 | Sponsor Protocol Number: OV.21 | Start Date*: 2010-07-30 | |||||||||||
Sponsor Name:NCIC Clinical Trial Group (NCIC CTG) | |||||||||||||
Full Title: A PHASE II/III STUDY OF INTRAPERITONEAL (IP) PLUS INTRAVENOUS (IV) CHEMOTHERAPY VERSUS IV CARBOPLATIN PLUS PACLITAXEL IN PATIENTS WITH EPITHELIAL OVARIAN CANCER OPTIMALLY DEBULKED AT SURGERY FOLLOW... | |||||||||||||
Medical condition: Epithelial ovarian cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.